AbbVie Inc. Rule 2.10 Announcement

 
TIDM0QCV 
 
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue 
 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE 
OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A 
VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION 
 
NORTH CHICAGO, Ill., Sept. 18, 2019 /PRNewswire/ -- In accordance with Rule 
2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. 
confirms that as of September 16, 2019 its issued share capital, excluding 
treasury shares, is comprised of 1,478,779,037 shares of common stock with a 
par value of $0.01 per share. AbbVie's common stock is traded on the NYSE and 
Chicago Stock Exchange under the symbol ABBV.  The International Securities 
Identification Number (ISIN) of the AbbVie common stock is US00287Y1091. 
 
AbbVie confirms that, as of the close of business on September 16, 2019, there 
were outstanding 6,826,241 options to purchase shares of common stock (the 
"Stock Options"), 7,947,357 restricted stock units (the "Restricted Stock 
Units") and 2,386,702 performance shares (the "Performance Shares"). Upon 
exercise, each Stock Option entitles the holder to purchase one share of common 
stock at the applicable exercise price. Upon vesting, each Restricted Stock 
Unit and Performance Share entitles the holder to receive one share of common 
stock. 
 
The Directors of AbbVie Inc. accept responsibility for the information 
contained in this announcement. To the best of their knowledge and belief 
(having taken all reasonable care to ensure such is the case), the information 
contained in this announcement is in accordance with the facts and does not 
omit anything likely to affect the import of such information. 
 
Any holder of 1% or more of any class of relevant securities of AbbVie Inc. may 
have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 
1997, Takeover Rules 2013. 
 
CONTACT: Adelle Infante, 1-847-938-8745 
 
 
 
END 
 

(END) Dow Jones Newswires

September 18, 2019 06:00 ET (10:00 GMT)